ABEONA THERAPEUTICS INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-20.2M | $-17.1M | $-20.5M | $-5.2M | $108.8M | $-12.0M | $-9.3M | $-30.3M |
| Depreciation & Amortization | $700.0K | $690.0K | $815.0K | $600.0K | $600.0K | $534.0K | $513.0K | $500.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.4M | $3.0M | $2.6M | $2.7M | $2.8M | $2.7M | $2.0M | $1.8M |
| Net Cash from Operating Activities | $-17.5M | $-19.8M | $-18.0M | $-21.2M | $-18.8M | $-18.4M | $-16.6M | $-12.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $479.0K | $935.0K | $1.2M | $2.5M | $2.9M | $1.4M | $606.0K | $404.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $15.7M | $5.0M | $9.6M | $-64.6M | $155.9M | $4.2M | $18.9M | $-6.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-3.3M | $-2.2M | $3.6M | $5.2M | $10.5M | $6.8M | $5.3M | $-299.0K |
| Net Change in Cash | $-5.1M | $-17.1M | $-4.8M | $-80.7M | $147.6M | $-7.4M | $7.6M | $-18.7M |
| Free Cash Flow | $-18.0M | $-20.7M | $-19.1M | $-23.7M | $-21.7M | $-19.8M | $-17.2M | $-12.6M |